During the last session, Werewolf Therapeutics Inc (NASDAQ:HOWL)’s traded shares were 0.25 million, with the beta value of the company hitting 0.66. At the end of the trading day, the stock’s price was $1.24, reflecting an intraday gain of 2.48% or $0.03. The 52-week high for the HOWL share is $4.18, that puts it down -237.1 from that peak though still a striking 51.61% gain since the share price plummeted to a 52-week low of $0.60. The company’s market capitalization is $55.65M, and the average trade volume was 430.21K shares over the past three months.
Werewolf Therapeutics Inc (HOWL) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. HOWL has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.37.
Werewolf Therapeutics Inc (NASDAQ:HOWL) trade information
Werewolf Therapeutics Inc (HOWL) registered a 2.48% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.48% in intraday trading to $1.24, hitting a weekly high. The stock’s 5-day price performance is 0.81%, and it has moved by 10.71% in 30 days. Based on these gigs, the overall price performance for the year is -58.80%.
The consensus price target of analysts on Wall Street is $12, which implies an increase of 89.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $12 and $12 respectively. As a result, HOWL is trading at a discount of -867.74% off the target high and -867.74% off the low.
Werewolf Therapeutics Inc (HOWL) estimates and forecasts
In the rating firms’ projections, revenue will decrease -100.00% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -20.76%. While earnings are projected to return -6.03% in 2025, the next five years will return -3.48% per annum.
HOWL Dividends
Werewolf Therapeutics Inc is due to release its next quarterly earnings on 2025-May-08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 4.28 million shares, is of MPM ASSET MANAGEMENT LLC’s that is approximately 10.2967% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $10.45 million.
